The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial.
 
Soumyajit Roy
Employment - Artera (I); Rush University
Research Funding - Swim Across America
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Shawn Malone
No Relationships to Disclose
 
Yilun Sun
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Pfizer
Research Funding - Janssen (Inst)
(OPTIONAL) Uncompensated Relationships - NCCN
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Boston Scientific; Janssen Oncology; Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Boston Scientific; Janssen
Research Funding - Janssen Oncology (Inst); Point Biopharma (Inst); ViewRay; ViewRay
 
Christopher J.D. Wallis
Honoraria - Abbvie; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Merck; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Nanostics; Precision Point Specialty; Sesen Bio
Research Funding - Bayer (Inst); Knight Therapeutics (Inst); Tolmar (Inst)
Travel, Accommodations, Expenses - Janssen; Knight Therapeutics; Knight Therapeutics; Tersera; Tolmar; Verity Pharmaceuticals
 
Angela Jia
Consulting or Advisory Role - Blue Earth Diagnostics; Myovant Sciences
Travel, Accommodations, Expenses - Myovant Sciences
 
Osama Mohamad
Employment - MD Anderson Cancer Center
 
Umang Swami
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Exelixis; Gilead Sciences; Imvax; Pfizer; Sanofi; Seagen
Research Funding - Exelixis (Inst); Janssen (Inst); Seattle Genetics/Astellas (Inst)
 
Michael Ong
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Pfizer/EMD Serono; Sanofi
Research Funding - AstraZeneca
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Simon Chowdhury
No Relationships to Disclose
 
Scott C. Morgan
Research Funding - Knight Therapeutics (Inst)